v3.25.2
OTHER EVENTS (Details Narrative)
6 Months Ended
Sep. 11, 2024
USD ($)
Aug. 23, 2024
Jun. 30, 2025
USD ($)
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Business Acquisition, Transaction Costs     $ 42,491
Business Development     957,670
Contribution of Property     $ 2,045,209
Etimated Framework Price Per Set of ITV-1 580    
Estimated Profits per set of ITV-1 $ 1,120    
Dimitar Slavchev Savov | Immunotech Laboratories BG, Ltd      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Affiliated Entity, Ownership Percentage     51.00%
Director [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Iinitial Down Payment for Business Development     $ 191,534
Nika Pharmaceuticals Ltd [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Real Estate Investment Property, at Cost     $ 2,016,562
Percentage of Ownership of Equity Interest     100.00%
Nika Europe [Member] | Nika Pharmaceuticals Ltd [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Percentage of Ownership At theTimeTransaction   99.99%